|    editor@medjpps.com

www.medjpps.com

Received date : 10-01-2022 Revised date : 31-01-2022 Accepted date : 10-02-2022 Published date : 31-03-2022

Mediterr J Pharm Pharm Sci 2 (1): 37-43, 2022

DOI: https://doi.org/10.5281/zenodo.6399474

Original Research


Potential risk factors for mortality in patients with COVID-19: A retrospective study

Entesar A.A. Omran, Amal M.A. Alshebani and Osama H. Almajdoub


Abstract :

Although severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection caused more than five million deaths throughout the world and more than five thousand deaths in Libya, a little is known about the mortality rate and the risk factors for death from this serious infectious disease in Libya. Thus, it is aimed in this study to identify the potential risk factors for mortality from SARS-CoV-2 infections among 176 Libyan COVID-19 patients in Zawia city. This research is a retrospective cohort study that was conducted on 176 randomly selected volunteers who had been infected with SARS-CoV-2 during a period of December 2020 to February 2021 in Zawia city, Libya. Following filling the prepared validated questionnaire by COVID-19 patients, the data was analyzed to determine the previously mentioned risk factors. The mean age (SD) of the total 176 participated COVID-19 patients was 45.06 (±17.7) and the mortality rate among these total involved cases (mild to severe cases) was 10.8%. It is found that the mortality among the severe COVID-19 cases was 41.3% and the mean age (SD) of COVID-19 deaths was 69.1 years (13.8) and 73.7% of them were 60 years old or older. In addition, it is found that 63.2% of the SARS-CoV-2 deaths were females and 78.9% of them had a positive history of chronic diseases. Moreover, it was found that the most common chronic diseases among COVID-19 deaths are diabetes mellitus and hypertension (73.3% and 53.3%, respectively). Collectively, it is concluded that COVID-19 elderly female patients aging 60 years or older with a positive history of chronic disease are more likely at high risk for death from SARS-CoV-2 infection among the participated COVID cases.

References

1. Kobayashi T, Jung S, Linton N, Kinoshita R, Hayashi K, Miyama T, Anzai A, Yang Y, Yuan B, Akhmetzhanov A, Suzuki A, Nishiura H (2020) Communicating the risk of death from novel coronavirus disease (COVID-19). Journal of Clinical Medicine. 9 (2): 580. doi: 10.3390/jcm9020580
2. Rabaan AA, Al-Ahmed SH, Al-Malkey MK, Alsubki R, Ezzikouri S, Al-Hababi FH, Sah R, ALMutai A, Alhumaid S, Al-Tawfiq JA, Al-Omari A, Al-Qaaneh AM, Al-Qahtani M, Tirupathi R, Al-Hamad MA, Al-Baghli N, Suliaman T, Alsubait A, Mehta R, Abass E, Alawi M, Alsharani F, Sherstha DB, Karobari MI, Silva S, Livis K, Aldana DK, Morales AJ (2021) Airborne transmission of SARS-CoV-2 is the dominant route of transmission: droplets and aerosols. Le Infezioni in Medicina. 29 (1): 10-19. PMID: 33664169.
3. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 395 (10223): 497-506. doi: 10.1016/S0140-6736(20)30183-5
4. Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, Cereda D, Coluccello A, Foti G, Fumagalli R, Lotti G, Latronico N, Lorini L, Merler S, Natalini G, Piatti A Ranieri MV, Scandroglio AM, Storti E, Cecconi M, Pesenti A (2020) Baseline characteristics and outcomes of 1591 patients infected with sars-cov-2 admitted to icus of the Lombardy Region, Italy. Journal of the American Medical Association. 323 (16): 1574-1581. doi: 10.1001/jama.2020.5394
5. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei C, Hui D, Du B, Li L (2020) Clinical Characteristics of Coronavirus Disease 2019 in China. The New England Journal of Medicine. 382 (18): 1708-1720. doi: 10.1056/NEJMoa2002032
6. NCDC. Coronavirus COVID-19. https://ncdc.org.ly/Ar/ (Accessed on January 10, 2022).
7. WHO, Health response to COVID-19 in Libya, WHO update # 23, Reporting period: 24 December 2020 to 31 January 2021. https://reliefweb.int/report/libya/who-libya-health-response-covid-19-libya-update-23-reporting-period-24-december-2020-31.
8. Cao J, Tu WJ, Cheng W, Yu L, Liu YK, Hu X, Liu Q (2020) Clinical features and short-term outcomes of 102 patients with corona virus disease 2019 in Wuhan, China. Clinical Infectious Diseases. 71 (15): 748-755. doi: 10.1093/cid/ciaa243
9. Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, Ma K, Xu D, Yu H, Wang H, Wang T, Guo Y, Chen J, Ding C, Zhang H, Huang J, Han M, Li S, Luo X, Zhao J, Ning Q (2020) Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. The British Medical Journal. 368: m1091. doi: 10.1136./bmj. m1091
10. Palaiodimos L, Kokkinidis DG, Li W, Karamanis D, Ognibene J, Arora S, Southern WN, Mantzoros CS (2020) Severe obesity is associated with higher in-hospital mortality in a cohort of patients with COVID-19 in the Bronx. New York. Metabolism Clinical and Experimental. 108: 1-10. 154262. doi: 10.1016/j.metabol.2020.154262
11. Biswas M, Rahaman S, Biswas TK, Haque Z, Ibrahim B (2020) Association of sex, age, and comorbidities with mortality in COVID-19 patients: a systematic review and meta-analysis. Intervirology. 9: 1-12. doi: 10.1159/ 000512592
12. Omran E, Almajdoub O, Bshaena A (2021) SARS-CoV-2 pandemic and its management in AL-Zawiyah city, Libya. Libyan Journal of Medical Research. 15 (2): 95-119. doi: Nil.
13. Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC (2020) Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease. 2019 (COVID-19): A Review. Journal of the American Medical Association. 324 (8): 782-793. doi: 10.1001/jama.2020.12839
14. Wu Z, McGoogan JM (2020) Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. Journal of the American Medical Association. 323 (13): 1239-1242. doi: 10.1001/jama.2020.2648
15. Al Mutair A, Al Mutairi A, Zaidi ARZ, Salih S, Alhumaid S, Rabaan AA and Al-Omari A (2021) Clinical predictors of COVID-19 mortality among patients in intensive care units: a retrospective study. International Journal of General Medicine. 14: 3719-3728. doi: 10.2147/IJGM.S313757
16. World Health Organization. (‎2021) COVID-19 clinical management: Living guidance, 25 January 2021. WHO. https://apps.who.int/iris/handle/10665/338882.
17. Deng Y, Liu W, Liu K, Fang YY, Shang J, Zhou L, Wang K, Leng F, Wei S, Chen L, Liu H (2020) Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 (COVID-19) in Wuhan, China: a retrospective study. Chinese Medical Journal. 133 (11): 1261-1267. doi: 10.1097/CM9.0000000000000824
18. Du Y, Tu L, Zhu P, Mu M, Wang R, Yang P, Wang X, Hu C, Ping R, Hu P, Li T, Cao F, Chang C, Hu Q, Jin Y, Xu G (2020) Clinical features of 85 fatal cases of COVID-19 from Wuhan: a retrospective observational study. American Journal of Respiratory and Critical Care Medicine. 201 (11): 1372-1379. doi: 10.1164/rccm.202003-0543OC
19. Huang Y, Yang R, Xu Y, Gong P (2020) Clinical characteristics of 36 non-survivors with COVID-19 in Wuhan, China. medRxiv. doi: 10.1101/2020.02.27.20029009
20. Qiu P, Zhou Y, Wang F, Wang H, Zhang M, Pan X, Zhao Q, Liu J (2020) Clinical characteristics, laboratory outcome characteristics, comorbidities, and complications of related COVID-19 deceased: a systematic review and meta-analysis. Aging Clinical and Experimental Research. 32 (9): 1869-1878. doi: 10.1007/s40520-020-01664-3
21. Du RH, Liang LR, Yang CQ, Wang W, Cao TZ, Li M, Guo GY, Du J, Zheng CL, Zhu Q, Hu M, Li XY, Peng P, Shi HZ (2020) Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study. The European Respiratory Journal. 55 (5): 2000524. doi: 10.1183/13993003.00524-2020
22. Korean Society of Infectious D, Korea Centers for Disease C, Prevention (2020) Analysis on 54 mortality cases of coronavirus disease 2019 in the Republic of Korea from January 19 to March 10, 2020. Journal of Korean Medical Science. 35 (12): e132. doi: 10.3346/jkms.2020.35.e132
23. Li X, Wang L, Yan S, Yang F, Xiang L, Zhu J, Shen B, Gong Z (2020) Clinical characteristics of 25 death cases with COVID-19: a retrospective review of medical records in a single medical center, Wuhan. China. International Journal of Infectious Diseases. 94: 128-132. doi: 10.1016/j.ijid.2020.03.053
24. Leng J, Goldstein DR (2010) Impact of aging on viral infections. Microbes and Infection. 12 (14-15): 1120-1124. doi: 10.1016/j.micinf.2010.08.009
25. Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, Huang H, Zhang L, Zhou X, DU C, Zhang Y, Song J, Wang S, Chao Y, Yang Z, Xu J, Zhou X, Chen D, Xiong W, Xu L, Zhou F, Jiang J, Bai C, Zheng J, Song Y (2020) Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 Pneumonia in Wuhan, China. Journal of the American Medical Association Internal Medicine. 180 (7): 934-943. doi: 10.1001/ jamainternmed.2020.0994
26. Fang L, Karakiulakis G, Roth M (2020) Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? The Lancet Respiratory Medicine. 8 (4): e21. doi: 10.1016/S2213-2600(20)30116-8
27. Espinosa OA, Zanetti ADS, Antunes EF, Longhi FG, Matos TA, Battaglini PF (2020) Prevalence of comorbidities in patients and mortality cases affected by SARS-CoV2: a systematic review and meta-analysis. Revista do Instituto de Medicina Tropical de Sao Paulo. 62: e43. doi: 10.1590/S1678-9946202062043
28. Parohan M, Yaghoubi S, Seraji A, Javanbakht MH, Sarraf P, Djalali M (2020) Risk factors for mortality in patients with Coronavirus disease 2019 (COVID-19) infection: A systematic review and meta-analysis of observational studies. The Aging Male. 23 (5): 1416-1424. doi: 10.1080/13685538.2020.1774748
29. Berbudi A, Rahmadika N, Cahyadi AI, Ruslami R (2020) Type 2 diabetes and its impact on the immune system. Current Diabetes Reviews. 16 (5): 442-449. doi: 10.2174/1573399815666191024085838

Citation :

Omran et al. (2022) Potential risk factors for mortality in patients with COVID-19: A retrospective study. Mediterr J Pharm Pharm Sci. 2 (1): 37-43. [Article number: 51]. https://doi.org/105281/zenodo.6399474

Share :